Alexandra P Charrow, MD, FAAD
SESSIONS
F013 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 8, 2024
•
9:00 AM - 11:00 AM
•
Room 1B
F071 Skin-environmental Interface: Dermatologic Challenges of Our Changing Climate and Environment
Mar 9, 2024
•
3:30 PM - 5:30 PM
•
Room 5B
DISCLOSURES
Avalo – Consultant (1099 relationship)(Fees); Incyte Corporation – Investigator(No Compensation Received); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(No Compensation Received); Sonoma Biotherapeutics – Investigator(No Compensation Received); UCB Pharma – Advisory Board(Honoraria); Wedbush Securities – Consultant (1099 relationship)(Honoraria);